Skip navigation
Results 1 - 10 of 90 for Parkinson disease 11
  1. Genetics Home Reference: Parkinson disease From the National Institutes of Health (National Library of Medicine)  
    ... Testing Registry: Parkinson disease 10 Genetic Testing Registry: Parkinson disease 11 Genetic Testing Registry: Parkinson disease 12 Genetic Testing Registry: Parkinson disease 13 ...
  2. Managing Advanced Parkinson Disease (National Parkinson Foundation, Inc.) - PDF  
    ... ala king, seem to work well.” Managing Advanced Parkinson Disease 11 DENTAL CARE Oral hygiene should remain an important ...
  3. Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation for Parkinson's Research)  
    ... NEWS MJFF LIVE September 15, 2014 Non-motor Parkinson's Disease Symptom Drug Now Available READ MORE September 11, 2014 Claudia Revilla: A Fox Trial Finder Fan ...
  4. Parkinson's Disease Foundation (Parkinson's Disease Foundation)  
    ... 1,000 survey respondents and four regional Parkinson’s disease organizations. Read More Parkinson's News Sep 11 2014 Droxidopa (NORTHERA™) Available in the US to ...
  5. Symptoms of Lewy Body Dementia (Lewy Body Dementia Association)  
    ... developed degenerative brain diseases, including Lewy body dementia, Parkinson’s disease, and multiple system atrophy, after an average of 11 years of receiving an RBD diagnosis. All three ...
  6. ... information, see http://clinicaltrials.gov/ct2/results?term=Parkinson's+disease+AND+NINDS . Winter 2014 Issue: Volume 8 Number 4 Page 11
  7. ... PD than GBA carriers. Among those who developed Parkinson’s, those with Gaucher (two mutated copies of GBA) developed the disease 11 years before the carriers (one mutated copy of ...
  8. ... up to 11 mg per day. More than 11 mg per day might not be safe. Excess manganese can cause serious side effects, including symptoms resembling Parkinson's disease, such as shaking (tremors). People who have trouble ...
  9. ... 14,200 (3,494) †1.0 (0.2) †11,900 (3,327) †0.8 (0.2) 37,400 (6,024) 2.6 (0.4) Parkinson’s disease . . . . . . . . . . . . . . . . . . . . . . . .(332) †18,900 (4,437) †1.3 (0. ...
  10. ... Practice parameter: neuroprotective strategies and alternative therapies for parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 2006 Apr 11;66(7): 976-82.
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · next